{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:49:29Z","timestamp":1761166169323,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.anndiagpath.2021.151833","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T08:07:26Z","timestamp":1632730046000},"page":"151833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Applying criteria for hepatocellular neoplasm of uncertain malignant potential reclassifies more than half of hepatocellular adenomas"],"prefix":"10.1016","volume":"55","author":[{"given":"Brent K.","family":"Larson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Guindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2021.151833_bb0005","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.humpath.2013.09.020","article-title":"Well-differentiated hepatocellular neoplasm of uncertain malignancy potential: proposal for a new diagnostic category","volume":"45","author":"Bedossa","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0010","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.humpath.2013.09.019","article-title":"Well-differentiated hepatocellular neoplasm of uncertain malignancy potential: proposal for a new diagnostic category\u2014reply","volume":"45","author":"Kakar","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/gut.2010.222109","article-title":"Changing trends in malignant transformation of hepatocellular adenoma","volume":"60","author":"Farges","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/ajcp\/aqx010","article-title":"A limited immunohistochemical panel can subtype hepatocellular adenomas for routine practice","volume":"147","author":"Larson","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0025","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/PAS.0b013e3182495c73","article-title":"Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma","volume":"36","author":"Singhi","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0030","first-page":"416","article-title":"Hepatocellular carcinoma coexisting with hepatocellular adenoma. incidental discovery after long-term oral contraceptive use","volume":"155","author":"Korula","year":"1991","journal-title":"West J Med"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00000478-199305000-00013","article-title":"Hepatocellular carcinoma arising in a focus of multilobular adenoma. A case report","volume":"17","author":"Ferrell","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0040","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1365-2559.1996.t01-3-297345.x","article-title":"Hepatocellular carcinoma arising in an adenoma: value of QBend 10 immunostaining in diagnosis of liver cell carcinoma","volume":"28","author":"Scott","year":"1996","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0045","first-page":"798","article-title":"Liver cell adenoma with concomitant hepatocellular carcinoma: a report of two cases","volume":"101","author":"Chuang","year":"2002","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0050","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00042737-200604000-00020","article-title":"Hepatocellular carcinoma in a liver-cell adenoma within a non-cirrhotic liver","volume":"18","author":"Burri","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0055","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.21068","article-title":"Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC","volume":"43","author":"Zucman-Rossi","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/hep.21684","article-title":"Telangiectatic adenoma: an entity associated with increased body mass index and inflammation","volume":"46","author":"Paradis","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0065","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/hep.21743","article-title":"Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry","volume":"46","author":"Bioulac-Sage","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0070","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/modpathol.2008.8","article-title":"Malignant transformation of hepatic adenomas","volume":"21","author":"Micchelli","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3904\/kjim.2009.24.2.147","article-title":"A case of hepatocellular carcinoma within hepatocellular adenoma in a non-cirrhotic male","volume":"24","author":"Kim","year":"2009","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0080","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/PAS.0b013e318218ca3f","article-title":"Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with \u03b2-catenin and glutamine synthetase positivity: case report and review of the literature","volume":"35","author":"Hechtman","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0085","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/modpathol.2014.50","article-title":"Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor","volume":"27","author":"Kakar","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0090","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-0035-1567827","article-title":"Hepatocellular carcinoma arising in an HNF-1\u03b1-mutated adenoma in a 23-year-old woman with maturity-onset diabetes of the young: a case report","volume":"35","author":"Stueck","year":"2015","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0095","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1053\/j.gastro.2009.07.061","article-title":"A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas","volume":"137","author":"Dokmak","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0100","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1477-2574.2010.00222.x","article-title":"Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases","volume":"12","author":"Stoot","year":"2010","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0105","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1365-2559.2007.02862.x","article-title":"Nuclear beta-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy","volume":"51","author":"Van der Borght","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0110","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ccr.2014.03.005","article-title":"Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation","volume":"25","author":"Pilati","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2559.2009.03343.x","article-title":"Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms","volume":"55","author":"Kakar","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0120","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.humpath.2012.07.019","article-title":"Atypical hepatocellular adenoma-like neoplasms with \u03b2-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas","volume":"44","author":"Evason","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0125","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/modpathol.2016.122","article-title":"Correlation of exon 3 \u03b2-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma","volume":"29","author":"Hale","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0130","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/hep.28638","article-title":"Genotype-phenotype correlation of CTNNB1 mutations reveals different \u03b2-catenin activity associated with liver tumor progression","volume":"64","author":"Rebouissou","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00428-014-1620-8","article-title":"Diffuse glutamine synthetase overexpression restricted to areas of peliosis in a \u03b2-catenin-activated hepatocellular adenoma: a potential pitfall in glutamine synthetase interpretation","volume":"465","author":"Berry","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0140","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/s41379-019-0282-0","article-title":"Genomic profiling of well-differentiated hepatocellular neoplasms with diffuse glutamine synthetase staining reveals similar genetics across the adenoma to carcinoma spectrum","volume":"32","author":"Joseph","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0145","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/modpathol.2015.83","article-title":"Pigmented hepatocellular adenomas have a high risk of atypia and malignancy","volume":"28","author":"Mounajjed","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2021.151833_bb0150","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.semdp.2006.09.001","article-title":"Gastrointestinal stromal tumors: pathology and prognosis at different sites","volume":"23","author":"Miettinen","year":"2006","journal-title":"Semin Diagn Pathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421001337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421001337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:34:22Z","timestamp":1761078862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913421001337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":30,"alternative-id":["S1092913421001337"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151833","relation":{},"ISSN":["1092-9134"],"issn-type":[{"type":"print","value":"1092-9134"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applying criteria for hepatocellular neoplasm of uncertain malignant potential reclassifies more than half of hepatocellular adenomas","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151833"}}